Methicillin-resistant Staphylococcus aureus pneumonia in adults (Q38230203)

31 August 2017

title

Methicillin-resistant Staphylococcus aureus pneumonia in adults (English)

1 reference

methicillin-resistant Staphylococcus aureus

31 August 2017

main subject

0 references

pneumonia

0 references

Staphylococcus aureus

object named as

Staphylococcus aureus

1 reference

Christian Woods

1

1 reference

31 August 2017

Gene Colice

series ordinal

2

1 reference

31 August 2017

publication date

17 July 2014

1 reference

Expert Review of Respiratory Medicine

31 August 2017

published in

1 reference

31 August 2017

volume

8

1 reference

31 August 2017

issue

5

1 reference

31 August 2017

page(s)

641-651

1 reference

Asian influenza A in Boston, 1957-1958. II. Severe staphylococcal pneumonia complicating influenza

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Pneumonia caused by methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Emergence of community-acquired meticillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotising community-onset pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Epidemiology and outcome of pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA) in Canadian hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, California

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

What is community-associated methicillin-resistant Staphylococcus aureus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

USA300 genotype community-associated methicillin-resistant Staphylococcus aureus as a cause of surgical site infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Emergence of USA300 MRSA in a tertiary medical centre: implications for epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Case definition for community-associated methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Invasive methicillin-resistant Staphylococcus aureus infections in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Augmented production of Panton-Valentine leukocidin toxin in methicillin-resistant and methicillin-susceptible Staphylococcus aureus is associated with worse outcome in a murine skin infection model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Risk factors for methicillin-resistant Staphylococcus aureus in patients with community-onset and hospital-onset pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Prediction of methicillin-resistant Staphylococcus aureus in patients with non-nosocomial pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Epidemiology, treatment, and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Methicillin-resistant Staphylococcus aureus necrotizing pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Community-acquired methicillin-resistant Staphylococcus aureus pneumonia: a clinical audit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Predictors of Outcome and Long-term Survival in Patients with Pleural Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

U.K. Controlled trial of intrapleural streptokinase for pleural infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

The bacteriology of pleural infection by genetic and standard methods and its mortality significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Current trends in rapid diagnostics for methicillin-resistant Staphylococcus aureus and glycopeptide-resistant enterococcus species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Diagnosis and treatment of Panton-Valentine leukocidin (PVL)-associated staphylococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Penetration of vancomycin into human lung tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Pleuropulmonary complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Intrapulmonary pharmacokinetics of linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

In vitro activity of ceftaroline against community-associated methicillin-resistant, vancomycin-intermediate, vancomycin-resistant, and daptomycin-nonsusceptible Staphylococcus aureus isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Comparative In Vitro Activities of Torezolid (DA-7157) against Clinical Isolates of Aerobic and Anaerobic Bacteria in South Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

In vitro activity of TR-700, the active ingredient of the antibacterial prodrug TR-701, a novel oxazolidinone antibacterial agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Tedizolid for the management of human infections: in vitro characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Impact of methicillin resistance on outcome of Staphylococcus aureus ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Antimicrobial peptide LL-37 and IDR-1 ameliorate MRSA pneumonia in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Influenza A virus exacerbates Staphylococcus aureus pneumonia in mice by attenuating antimicrobial peptide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Staphylococcal Enterotoxin B-specific monoclonal antibody 20B1 successfully treats diverse Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Vaccination against Staphylococcus aureus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2014.940323

10.1586/17476348.2014.940323

21 January 2018

Identifiers

DOI

1 reference

31 August 2017

1 reference